← Open Payments lookup

MALLORY VANDEVENDER: Open Payments

NPI 1578218616 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,849 in 185 payments from 23 companies in 2025. Trend: 2023 $2,484 · 2024 $2,134 · 2025 $2,849

Food & beverage: $2,849
CompanyPaymentsAmount
ABBVIE INC.44$511
AstraZeneca Pharmaceuticals LP20$427
Novo Nordisk Inc22$285
Corcept Therapeutics16$239
PFIZER INC.11$186
GlaxoSmithKline, LLC.10$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$167
Lilly USA, LLC14$159
Lundbeck LLC6$123
Phathom Pharmaceuticals, Inc.6$95

Products named: Korlym, UBRELVY, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, CAPLYTA, REXULTI, VRAYLAR.

Industry payments across MS — which companies pay providers there.